FindTrial
Sign In

RELATING BIOMARKER EXPRESSION TO LYMPH NODAL INVOLVEMENT IN CARCINOMA BREAST

CORRELATION OF BIOMARKERS OF EPITHELIAL MESENCHYMAL TRANSITION PATHWAY TO AXILLARY LYMPH NODE INVOLVEMENT: A PROSPECTIVE EXPLORATORY STUDY - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/01/061365
Enrollment
50
Registered
2024-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

None listed

Sponsors

Kanmathareddy Amulya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients aged more than 18 years and less than 75 years. 2)All patients with biopsy proven primary invasive ductal carcinoma(IDC)(AJCC 8th) of stages I-III. 3)Patients undergoing either BCS/simple mastectomy with positive SLNB or MRM 4)Patients giving informed consent.

Exclusion criteria

Exclusion criteria: 1)Negative sentinel lymph node biopsy 2)Inflammatory breast cancer 3)Recurrent breast cancer 4)Pregnant female

Design outcomes

Primary

MeasureTime frame
To measure the EMT biomarker expression using immunohistochemistry in breast cancer specimen to axillary lymph node involvementTimepoint: Not applicable—

Secondary

MeasureTime frame
To corelate the presence of biomarkers with clinicopathological characteristicsTimepoint: Not applicable—

Countries

India

Contacts

Public ContactDr Amulya

AIIMS Rishikesh

farhanul1973huda@gmail.com09997533211

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026